Press Trust of India on MSN22h
Veeda Clinical Research refiles draft IPO papers with SebiClinical research organisation Veeda Clinical Research has re-filed preliminary papers with markets regulator Sebi seeking ...
Nifty 50 has delivered 93% returns, but when adjusted for the 37% depreciation of the Indian rupee (INR) against the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback